Compound ID | 3484
Class: Efflux pump inhibitor
| Details of activity: | Active against Mycobacterium abscessus |
| Description: | Synthetic compound; shows synergistic or additive effects with clarithromycin, linezolid, and amikacin |
| Year first mentioned: | 2021 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|